To view this email as a web page, click here

Today's Rundown

Featured Story

Johnson & Johnson's COVID-19 vaccine scores longer shelf life just as millions of doses were set to expire

Just as millions of Johnson & Johnson COVID-19 vaccines were set to expire by June's end, the FDA on Thursday said the jabs could be kept on the shelf a month and half longer than originally suggested.

read more

Top Stories

OSHA releases new standard to protect front-line health workers from COVID-19

OSHA released a new emergency temporary standard Thursday that outlines requirements for hospitals and other providers to protect their workers from contracting COVID-19.

read more

Vexed by vectors: How COVID-19 vaccine and cell and gene players are tackling the viral vector bottleneck

To crank out enough viral vectors to meet short-term demand for cell and gene therapies, not to mention some COVID-19 vaccines, the industry would need to have 3 billion to 6 billion liters of bioreactor capacity a year, GlobalData figures. It currently has less than 1% of that.

read more

COVID-19 tracker: CDC reports higher rate of heart inflammation cases after Pfizer, Moderna jabs

The CDC said there's been a higher-than-expected level of heart inflammation cases following a second shot from either Pfizer-BioNTech or Moderna, although a direct link hasn't been established. The FDA awarded Johnson & Johnson's shot a longer shelf life just as millions of doses were set to expire. And more headlines.

read more

Kaiser Permanente is leveraging its wealth of member and community data to craft new vaccine promotion programs

The large integrated health system has announced a sweepstakes lottery, community grants and other outreach programs supporting President Joe Biden's Fourth of July vaccination goal.

read more